Biopharmaceutical CMO and CRO Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Biopharmaceutical CMO and CRO Market covers analysis By Source (Mammalian, Non-Mammalian); Service Type (Contract Manufacturing, Contract Research); Product (Biologics, Biosimilars) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00007162
  • Category : Healthcare IT
  • No. of Pages : 150
Buy Now

Biopharmaceutical CMO and CRO Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET OVERVIEW

A contract research organization (CRO) is an enterprise that offers research and development services to the pharmaceutical and biotechnology industries. These companies collaborate with other companies to arrange and conduct clinical trials in order to test the novel molecule before it is approved. Contract manufacturing organizations (CMOs) provide manufacturing services in a range of volumes, from small amounts for preclinical research and development to larger volumes required for clinical trials and commercialization.

MARKET SCOPE

The Global Biopharmaceutical CMO And CRO Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the biopharmaceutical CMO and CRO market with detailed market segmentation by source, service type and product. The report provides key statistics on the market status of the leading biopharmaceutical CMO and CRO market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on source the market is segmented as, mammalian and non-mammalian.
  •   Based on service type the market is segmented as, contract manufacturing and contract research.
  •   Based on product the market is bifurcated as, biologics and biosimilars.

MARKET DYNAMICS
Drivers:

  •   Increasing R&D expenditures by biopharmaceutical companies and rising outsourcing activities.
  •   Increasing number of clinical trials because of rising pool of novel drug candidates.
  •   Growing demand for biosimilar and generic medicines is also expected to create significant growth opportunities for the market.

Restraints:

  •   However, presence of stringent regulatory framework along with complexities asociated with service are likely to restrain market growth during the forecast period.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The biopharmaceutical CMO and CRO market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the biopharmaceutical CMO and CRO market in these regions.

IMPACT OF COVID-19 ON BIOPHARMACEUTICAL CMO AND CRO MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Biopharmaceutical CMO and CRO Market Report Analysis

Biopharmaceutical CMO and CRO Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • AGC Biologics
  • Boehringer Ingelheim International GmbH
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • TOYOBO CO., LTD
  • JRS PHARMA
  • Lonza
  • PRA Health Sciences, Inc.
  • ProBioGen AG
  • Rentschler Biopharma SE

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Source
  • Mammalian
  • Non-Mammalian
By Service Type
  • Contract Manufacturing
  • Contract Research
By Product
  • Biologics
  • Biosimilars
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The report covers key developments in the biopharmaceutical CMO and CRO market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from biopharmaceutical CMO and CRO market are anticipated to lucrative growth opportunities in the future with the rising demand for biopharmaceutical CMO and CRO in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the biopharmaceutical CMO and CRO market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   AGC Biologics
  •   Boehringer Ingelheim International GmbH
  •   FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  •   TOYOBO CO., LTD
  •   JRS PHARMA
  •   Lonza
  •   PRA Health Sciences, Inc.
  •   ProBioGen AG
  •   Rentschler Biopharma SE
  •   Samsung BioLogics
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Biopharmaceutical CMO and CRO Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Source
  • Mammalian
  • Non-Mammalian
By Service Type
  • Contract Manufacturing
  • Contract Research
By Product
  • Biologics
  • Biosimilars
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AGC Biologics
  • Boehringer Ingelheim International GmbH
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • TOYOBO CO., LTD
  • JRS PHARMA
  • Lonza
  • PRA Health Sciences, Inc.
  • ProBioGen AG
  • Rentschler Biopharma SE
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. AGC Biologics
    2. Boehringer Ingelheim International GmbH
    3. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
    4. TOYOBO CO., LTD
    5. JRS PHARMA
    6. Lonza
    7. PRA Health Sciences, Inc.
    8. ProBioGen AG
    9. Rentschler Biopharma SE
    10. Samsung BioLogics

    Trends and growth analysis reports related to Healthcare IT : READ MORE..